Stuart Firth‐Clark

504 total citations
12 papers, 361 citations indexed

About

Stuart Firth‐Clark is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Stuart Firth‐Clark has authored 12 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Computational Theory and Mathematics. Recurrent topics in Stuart Firth‐Clark's work include Computational Drug Discovery Methods (4 papers), Cancer therapeutics and mechanisms (3 papers) and Estrogen and related hormone effects (3 papers). Stuart Firth‐Clark is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Cancer therapeutics and mechanisms (3 papers) and Estrogen and related hormone effects (3 papers). Stuart Firth‐Clark collaborates with scholars based in United Kingdom, Australia and Spain. Stuart Firth‐Clark's co-authors include Mark Mackey, Paolo Tosco, Maximilian Kühn, Antonia S. J. S. Mey, Julien Michel, Stewart B. Kirton, Alfonso T. García‐Sosa, Ricardo L. Mancera, William R. Harris and Henriëtte M. G. Willems and has published in prestigious journals such as Nucleic Acids Research, Journal of Medicinal Chemistry and Journal of Chemical Information and Modeling.

In The Last Decade

Stuart Firth‐Clark

12 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart Firth‐Clark United Kingdom 9 253 139 55 44 30 12 361
Billy J. Williams‐Noonan Australia 11 272 1.1× 152 1.1× 65 1.2× 61 1.4× 33 1.1× 15 464
Daisuke Takaya Japan 14 306 1.2× 144 1.0× 90 1.6× 53 1.2× 31 1.0× 29 447
Kuan Pern Tan Singapore 7 307 1.2× 65 0.5× 66 1.2× 30 0.7× 21 0.7× 8 402
Alexander S. Bayden United States 9 328 1.3× 107 0.8× 76 1.4× 77 1.8× 17 0.6× 14 469
Yalong Cong China 13 299 1.2× 138 1.0× 52 0.9× 49 1.1× 93 3.1× 30 478
Tobias Wulsdorf Germany 7 200 0.8× 88 0.6× 64 1.2× 49 1.1× 10 0.3× 8 299
Diego E. B. Gomes Brazil 11 196 0.8× 83 0.6× 66 1.2× 35 0.8× 14 0.5× 23 314
Ewa I. Chudyk United Kingdom 12 242 1.0× 117 0.8× 54 1.0× 39 0.9× 17 0.6× 13 405
Juan Pablo Arcon Argentina 10 329 1.3× 106 0.8× 52 0.9× 39 0.9× 20 0.7× 15 407
Stefania Pfeiffer‐Marek Germany 11 254 1.0× 78 0.6× 48 0.9× 21 0.5× 17 0.6× 14 329

Countries citing papers authored by Stuart Firth‐Clark

Since Specialization
Citations

This map shows the geographic impact of Stuart Firth‐Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Firth‐Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Firth‐Clark more than expected).

Fields of papers citing papers by Stuart Firth‐Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Firth‐Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Firth‐Clark. The network helps show where Stuart Firth‐Clark may publish in the future.

Co-authorship network of co-authors of Stuart Firth‐Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Firth‐Clark. A scholar is included among the top collaborators of Stuart Firth‐Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Firth‐Clark. Stuart Firth‐Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Zhang, Jihui, Jie Chen, Jonathan P. Richardson, et al.. (2022). Targeting an Initiator Allergen Provides Durable and Expansive Protection against House Dust Mite Allergy. ACS Pharmacology & Translational Science. 5(9). 735–751. 3 indexed citations
2.
Kühn, Maximilian, Stuart Firth‐Clark, Paolo Tosco, et al.. (2020). Assessment of Binding Affinity via Alchemical Free-Energy Calculations. Journal of Chemical Information and Modeling. 60(6). 3120–3130. 149 indexed citations
3.
Vilaboa, Nuria, et al.. (2017). New inhibitor targeting human transcription factor HSF1: effects on the heat shock response and tumor cell survival. Nucleic Acids Research. 45(10). 5797–5817. 56 indexed citations
4.
Donahue, Elizabeth, Lisa F. Dawson, Esmeralda Valiente, et al.. (2014). Clostridium difficilehas a single sortase, SrtB, that can be inhibited by small-molecule inhibitors. BMC Microbiology. 14(1). 219–219. 25 indexed citations
5.
Perrior, Trevor R., Kerry Jenkins, Stuart Firth‐Clark, et al.. (2014). The Discovery of Potent, Selective, and Reversible Inhibitors of the House Dust Mite Peptidase Allergen Der p 1: An Innovative Approach to the Treatment of Allergic Asthma. Journal of Medicinal Chemistry. 57(22). 9447–9462. 21 indexed citations
6.
Firth‐Clark, Stuart, Stewart B. Kirton, Henriëtte M. G. Willems, & Anthony A. Williams. (2008). De Novo Ligand Design to Partially Flexible Active Sites:  Application of the ReFlex Algorithm to Carboxypeptidase A, Acetylcholinesterase, and the Estrogen Receptor. Journal of Chemical Information and Modeling. 48(2). 296–305. 12 indexed citations
7.
Dean, Philip M., Stuart Firth‐Clark, William R. Harris, Stewart B. Kirton, & Nikolay P. Todorov. (2006). SkelGen: a general tool for structure-basedde novoligand design. Expert Opinion on Drug Discovery. 1(2). 179–189. 18 indexed citations
8.
Firth‐Clark, Stuart, et al.. (2006). Exhaustive de novo Design of Low-Molecular-Weight Fragments Against the ATP-Binding Site of DNA-Gyrase. Journal of Chemical Information and Modeling. 46(3). 1168–1173. 10 indexed citations
9.
Firth‐Clark, Stuart, Henriëtte M. G. Willems, Anthony A. Williams, & William R. Harris. (2005). Generation and Selection of Novel Estrogen Receptor Ligands Using the De Novo Structure-Based Design Tool, SkelGen. Journal of Chemical Information and Modeling. 46(2). 642–647. 25 indexed citations
10.
García‐Sosa, Alfonso T., Stuart Firth‐Clark, & Ricardo L. Mancera. (2005). Including Tightly‐Bound Water Molecules in de Novo Drug Design. Exemplification Through the in Silico Generation of Poly(ADP‐ribose)polymerase Ligands.. ChemInform. 36(32). 1 indexed citations
11.
García‐Sosa, Alfonso T., Stuart Firth‐Clark, & Ricardo L. Mancera. (2005). Including Tightly-Bound Water Molecules in de Novo Drug Design. Exemplification through the in Silico Generation of Poly(ADP-ribose)polymerase Ligands. Journal of Chemical Information and Modeling. 45(3). 624–633. 37 indexed citations
12.
Firth‐Clark, Stuart, Christopher F. Rodriquez, & Ian H. Williams. (1997). Hydroxyoxiranone: an ab initio MO investigation of the structure and stability of a model for a possible α-lactone intermediate in hydrolysis of sialyl glycosides. Journal of the Chemical Society Perkin Transactions 2. 1943–1948. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026